Medpace Holdings Other Current Liab Over Time
| MEDP Stock | USD 335.21 2.61 0.77% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Medpace Holdings Performance and Medpace Holdings Correlation. Medpace |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medpace Holdings. If investors know Medpace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medpace Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.356 | Earnings Share 11.42 | Revenue Per Share 67.019 | Quarterly Revenue Growth 0.083 | Return On Assets 0.1431 |
The market value of Medpace Holdings is measured differently than its book value, which is the value of Medpace that is recorded on the company's balance sheet. Investors also form their own opinion of Medpace Holdings' value that differs from its market value or its book value, called intrinsic value, which is Medpace Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medpace Holdings' market value can be influenced by many factors that don't directly affect Medpace Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medpace Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medpace Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medpace Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Current Liab Analysis
Compare Medpace Holdings and related stocks such as IQVIA Holdings, Neogen, and ICON PLC Other Current Liab Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IQV | 703.5 M | 703.5 M | 721 M | 832.6 M | 819 M | 815.5 M | 1.6 B | 1.7 B | 2 B | 319 M | 2.5 B | 2.6 B | 2.8 B | 2.9 B | 1.7 B |
| NEOG | 900 K | 9.2 M | 8.5 M | 11.6 M | 11.8 M | 12.8 M | 19.8 M | 17.9 M | 19.2 M | 22.8 M | 26.6 M | 35.6 M | 57.2 M | 48.6 M | 51.1 M |
| ICLR | 18.2 M | 145.5 M | 2.5 M | 191.6 M | 251.1 M | 231.9 M | 190.7 M | 6.5 M | 5.2 M | 362.3 M | 360.9 M | 899.7 M | 961.4 M | 879 M | 922.9 M |
| QGEN | 3.3 M | 245 M | 220.8 M | 235.3 M | 205.2 M | 165.3 M | 211.6 M | 214.9 M | 354.3 M | 532.8 M | 273.3 M | 455.5 M | 381 M | 306 M | 321.3 M |
| WAT | 52.2 M | 145.8 M | (121.5 M) | (128.1 M) | (129.7 M) | (212.1 M) | (216.6 M) | (231.4 M) | (233.1 M) | (225.4 M) | 356.8 M | 328.2 M | 229.1 M | 222.3 M | 233.4 M |
| IDXX | 3.5 M | 141.4 M | 137.7 M | 148.9 M | 195.4 M | 205.5 M | 236.1 M | 253.4 M | 260.7 M | 322.9 M | 355.2 M | 396.4 M | 364.7 M | 372.4 M | 391 M |
| CRL | 11.2 M | 111.2 M | 115.2 M | 139.7 M | 152.3 M | 176.7 M | 206.1 M | 237.1 M | 315.4 M | 388.3 M | 409.6 M | 553.1 M | 531.3 M | 605.5 M | 635.8 M |
| RVTY | 122 M | 423.3 M | 256.1 M | 268.3 M | 255.4 M | 244.5 M | 271.2 M | 347.9 M | 380.8 M | 358.7 M | 412.5 M | 764.4 M | 588.4 M | 267.9 M | 308.8 M |
| LH | 20.6 M | 1.4 B | 287.6 M | 295.7 M | 314.9 M | 633.1 M | 595.2 M | 632.9 M | 870 M | 942.4 M | 784.2 M | 967 M | 1.6 B | 504.3 M | 478.7 M |
| MTD | 167.9 M | 313.9 M | 307.3 M | 318 M | 334.6 M | 349.7 M | 321.6 M | 395.2 M | 382.7 M | 390.6 M | 376.1 M | 445.1 M | 405.3 M | 356.4 M | 304.8 M |
| TWST | 353 K | 353 K | 353 K | 353 K | 353 K | 353 K | 6.6 M | 939 K | 817 K | 14.3 M | 27.7 M | 53.5 M | 40 M | 34.9 M | 21.9 M |
Medpace Holdings and related stocks such as IQVIA Holdings, Neogen, and ICON PLC Other Current Liab description
My Equities
My Current Equities and Potential Positions
| Medpace Holdings | MEDP |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Ohio; U.S.A |
| Exchange | NASDAQ Exchange |
USD 335.21
Additional Tools for Medpace Stock Analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.